| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $583.38 | $5,542,093.67 | -2.8% | - | - | |
| Oct 21, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $560.07 | $5,320,680.75 | -2.8% | - | - | |
| Oct 20, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $553.87 | $5,261,740.62 | -2.8% | - | - | |
| Oct 19, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $543.32 | $5,161,575.77 | -2.8% | - | - | |
| Oct 19, 2026 | INM Inmed Pharmaceuticals Inc. | Adar1 Capital Management, LLC78 | 10% Owner | Buy | 1,087 | $1.32 | $1,434.84 | +0.1% | - | - | |
| Oct 16, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $534.66 | $5,079,274.86 | -2.8% | - | - | |
| Oct 15, 2026 | AQST Aquestive Therapeutics, Inc. | Barber Daniel77 | President And CEO | Sell | 25,000 | $4.22 | $105,600.00 | -3.8% | - | - | |
| Oct 15, 2026 | UTHR United Therapeutics Corporation | Mahon Paul A46 | EVP &General Counsel | Sell | 8,300 | $544.30 | $4,517,708.96 | -15.5% | - | - | |
| Oct 15, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $546.65 | $5,193,199.71 | -2.8% | - | - | |
| Oct 15, 2026 | ELAN Elanco Animal Health Incorporated | Bettington Timothy J | See Remarks | Sell | 4,350 | $23.00 | $100,050.00 | -3.0% | - | - | |
| Oct 15, 2026 | ANIP Ani Pharmaceuticals, Inc. | Lalwani Nikhil66 | President &CEO | Sell | 5,400 | $71.89 | $388,206.00 | -1.6% | - | - | |
| Oct 15, 2026 | INM Inmed Pharmaceuticals Inc. | Adar1 Capital Management, LLC78 | 10% Owner | Buy | 9,569 | $1.33 | $12,718.80 | +1.0% | - | - | |
| Oct 14, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $539.99 | $5,129,873.02 | -2.8% | - | - | |
| Oct 14, 2026 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 3,461 | $29.06 | $100,576.66 | -1.2% | - | - | |
| Oct 13, 2026 | ANIP Ani Pharmaceuticals, Inc. | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $73.59 | $36,795.00 | -0.7% | - | - | |
| Oct 13, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $545.52 | $5,182,414.18 | -2.8% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Khindri Sanjeev | Chief Development Officer | Sell | 1,101 | $28.48 | $31,356.48 | -1.7% | - | - | |
| Oct 12, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $550.70 | $5,231,666.41 | -2.8% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Kaseta Michael54 | CFO And COO | Sell | 18,938 | $28.48 | $539,354.24 | -5.3% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Saggar Rajeev | Chief Medical Officer | Sell | 9,218 | $28.48 | $262,528.64 | -6.8% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Schundler Russell57 | General Counsel | Sell | 13,692 | $28.48 | $389,948.16 | -2.2% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Krepp Sarah | Chief Human Resource Officer | Sell | 5,245 | $28.48 | $149,377.60 | -4.4% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Jeffs Roger64 | Chief Executive Officer | Sell | 32,744 | $28.48 | $932,549.12 | -2.8% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Adair Jason | Chief Business Officer | Sell | 7,301 | $28.48 | $207,932.48 | -3.9% | - | - | |
| Oct 12, 2026 | LQDA Liquidia Corporation | Moomaw Scott | Chief Commercial Officer | Sell | 8,863 | $28.48 | $252,418.24 | -4.7% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.